Shanghai Yizhong Pharmaceutical Co., Ltd.

SSE:688091.SS

46.75 (CNY) • At close June 11, 2025
Overzicht | Financiële gegevens

Cijfers zijn in miljoenen (behalve de cijfers per aandeel en de ratio's) CNY.

2025 Q12024 Q42024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Omzet 71.0324.73947.45152.96468.37980.68778.771108.03192.469.63494.45337.52934.3424.0780000000
Kosten van de omzet 13.2224.0352.5962.9693.7334.7985.0356.7737.1035.1786.2583.2162.3180.2960000000
Brutowinst 57.810.70444.85549.99564.64675.88973.737101.25885.29664.45688.19434.31332.0243.7820000000
Brutowinstmarge 0.8140.1490.9450.9440.9450.9410.9360.9370.9230.9260.9340.9140.9330.9270000000
Onderzoek- en ontwikkelingskosten 9.27711.8610.0149.7345.5965.7437.7226.3822.6033.1772.211.0821.4560.3043.8575.2363.8435.4174.2353.5694.673
Algemene en administratieve kosten 6.214-15.21616.8875.8668.3755.22813.4696.2598.548-2.835.334-0.9452.223-6.61910.5862.8613.149-4.557.2750.7370.747
Verkoop- en marketingkosten 28.209-17.26845.36727.90525.58227.85730.24733.74414.78629.55648.0626.644.7731.8240.4940-00000
Verkoop-, algemene en administratieve kosten 34.423-36.89262.29238.69933.39940.82143.71640.00323.33426.72653.3965.6956.996-4.79511.082.8613.149-4.557.2750.7370.747
Overige kosten -2.38746.645-27.076-2.634-0.976-0.037-2.667-1.2750.14-3.547-3.3822.982-0.2143.783-4.807-6.722-5.5047.676-0.0011.441-0.005
Bedrijfskosten 41.31318.00245.2348.43338.99546.60148.59849.62526.07726.35652.2249.7598.238-0.70910.131-6.722-5.5048.5436.265.7467.087
Bedrijfsresultaat 16.498-10.674-6.9991.56225.65129.28832.88758.00866.14646.92143.91830.91729.83211.442-8.498-6.722-5.504-7.165-4.743-4.364-5.569
Bedrijfsresultaat ratio 0.232-2.252-0.1470.0290.3750.3630.4170.5370.7160.6740.4650.8240.8692.8060000000
Totaal overige inkomsten en kosten netto -1.008-7.2756.161-2.634-0.9766.3375.081-1.275-1.824-0.608-0.695-0.7230-0.60.6000-0.0010-0.005
Inkomen voor belasting 15.49-33.282-0.8375.46733.46935.62430.21956.73464.32346.31343.22330.19429.83210.842-7.898-6.722-5.504-7.165-4.744-4.364-5.574
Inkomen voor belasting ratio 0.218-7.023-0.0180.1030.4890.4420.3840.5250.6960.6650.4580.8050.8692.6590000000
Belastingkosten 1.304-5.588-0.9980.1374.2914.6943.7057.6499.2987.6240.036-0.041-0.913-4.8571.6337.945-0.0541.3781.517-0.5350.081
Nettowinst 14.186-27.6950.1615.33129.17830.9326.51449.08555.02538.68943.18730.23530.74416.127-7.898-6.722-5.504-7.165-4.744-4.364-5.574
Nettowinstmarge 0.2-5.8440.0030.1010.4270.3830.3370.4540.5960.5560.4570.8060.8953.9550000000
WPA (Winst Per Aandeel) 0.07-0.1770.0010.0260.180.20.170.310.350.240.410.290.210.19-0.099-0.084-0.047-0.09-0.06-0.055-0.052
Verwaterde WPA 0.07-0.1770.0010.0260.180.20.170.310.350.240.410.290.210.19-0.099-0.084-0.047-0.09-0.06-0.055-0.052
EBITDA 14.212-27.801-0.7318.63636.57838.00532.64158.55166.15447.93245.33431.78831.42611.015-7.584-11.996-5.504-9.391-5.443-4.233-5.507
EBITDA ratio 0.2-5.866-0.0150.1630.5350.4710.4140.5420.7160.6880.480.8470.9152.7010000000